,outcome,arm 1,arm 2,comparative statistic,95% CI,p-value,note
0,intervention,,topotecan,,,,
0,progression-free survival rates,NR,NR,NR,NR,P =.095,similar
0,Severe hematologic toxicity,NR,more common,NR,NR,NR,NR
